Leukemia Research
Volume 32, Issue 2 , Pages 251-254, February 2008

Arsenic trioxide, thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients

Division of Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, PR China

Received 6 April 2007; received in revised form 25 May 2007; accepted 28 May 2007. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(07)00242-1

doi:10.1016/j.leukres.2007.05.025

Leukemia Research
Volume 32, Issue 2 , Pages 251-254, February 2008

Article Tools